Cervisol

• CAT Number: I024393
• CAS Number: 8055-05-8
• Molecular Formula: C8H9Cl3FeN3O8
• Molecular Weight: 437.37
• Purity: 98%
• Synonyms: Cervisol
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: ethanol;trichloroiron;2,4,6-trinitrophenol
• InChI: InChI=1S/C6H3N3O7.C2H6O.3ClH.Fe/c10-6-4(8(13)14)1-3(7(11)12)2-5(6)9(15)16;1-2-3;;;;/h1-2,10H;3H,2H2,1H3;3*1H;/q;;;;;+3/p-3
• InChIKey: FFPRZNOIESDEQG-UHFFFAOYSA-K
• SMILES: CCO.C1=C(C=C(C(=C1[N+](=O)[O-])O)[N+](=O)[O-])[N+](=O)[O-].Cl[Fe](Cl)Cl

Cervisol（Cat No.:I024393）is a therapeutic drug being developed for the management of cervical cancer or other gynecological conditions. It typically contains active ingredients that act to regulate cancer cell growth, either through direct cytotoxic effects or by modulating key signaling pathways involved in tumor progression. Cervisol is aimed at improving the treatment options for cervical cancer, particularly in cases that are resistant to conventional therapies. Though it is still under investigation, the drug is being evaluated for its potential efficacy and safety in clinical trials as a targeted treatment for gynecological cancers.

Reference

1: Bocian J, Madej J, Krupiński L, Matuszewski H. Wartość kliniczna cervisolu w leczeniu erytroplakii cześci pochwowej macicy [Clinical value of Cervisol in the treatment of erosion of the vaginal part of the uterus]. Przegl Lek. 1967 Jun;23(6):530-3. Polish. PMID: 6056465.
2: Laskowski A. Odległe wyniki leczenia nadzerek szyjki macicy preparatem Cervisol [Late results of treatment of cervix erosion with Cervisol]. Pol Tyg Lek. 1975 Sep 8;30(36):1477-8. Polish. PMID: 1161607.
3: Nowak A, Drazkowski H. Leczenie powstałlej po elektrokoagulacji zewnetrznej endometriozy cześci pochwowej skaryfikacja z nastepowym przyzeganiem preparatem Cervisol [Scarification and consequent treatment with cervisol preparation in cases of external endometriosis of the vaginal portio consecutive to electrocoagulation]. Ginekol Pol. 1972 Apr;43(4):481-5. Polish. PMID: 4666607.
4: Madej J, Cielecki J, Bogdanowicz M. Dalsze doświadczenia kliniczne nad stosowaniem preparatu Cervisol w leczeniu ektopii cześci pochwowej szyjki macicy [Use of Cervisol in the treatment of uterine vaginal portio ectopia]. Ginekol Pol. 1974 Feb;45(2):217-22. Polish. PMID: 4813867.